Abhijit Karwa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
RATIONALE Patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) continue to have an unacceptably high mortality rate despite the progress achieved with pulmonary arterial vasodilator therapies. OBJECTIVES We sought to determine whether SSc-PAH is a clinically distinct pulmonary vascular disease phenotype when compared with(More)
  • 1